Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v3-FR
Language English French
Date Updated 2019-03-14 2019-01-11
Drug Identification Number 02332957 02332957
Brand name ATACAND PLUS ATACAND PLUS
Common or Proper name candesartan cilexetil and hydrochlorothiazide tablets candesartan cilexetil and hydrochlorothiazide tablets
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 25MG 32MG 25MG 32MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 2 X 15 tablet blisters 2 X 15 tablet blisters
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-01-21 2019-01-21
Actual start date
Estimated end date 2019-03-15 2019-02-11
Actual end date 2019-03-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Fulfilling additional Health Canada requirements Fulfilling additional Health Canada requirements
Health Canada comments